{"gene":"BET1L","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":1997,"finding":"GS15 (BET1L) is a 15 kDa integral membrane protein highly enriched in Golgi membranes that behaves biochemically as a SNARE protein, identified as a mammalian homolog of yeast Bet1p involved in vesicular transport.","method":"Affinity-purified polyclonal antibodies, indirect immunofluorescence microscopy, biochemical fractionation/characterization","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct biochemical characterization of protein behavior as a SNARE, subcellular localization by immunofluorescence and fractionation, single lab with two orthogonal methods","pmids":["9242691"],"is_preprint":false},{"year":2002,"finding":"GS15 (BET1L) localizes to medial-cisternae of the Golgi apparatus (not the IC/ER exit sites), exists in a distinct SNARE complex with syntaxin 5, GS28, and Ykt6 (but not with ER-to-Golgi-exclusive SNAREs), co-immunoprecipitates with COPI coat components from Golgi extracts, and is essential for normal Golgi structure — its knockdown redistributes Golgi markers into small dotty/diffuse patterns.","method":"Immuno-electron microscopy, co-immunoprecipitation, siRNA knockdown, overexpression of dominant-negative mutants, indirect immunofluorescence","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, immuno-EM localization, loss-of-function siRNA with defined Golgi phenotype, dominant-negative overexpression, multiple orthogonal methods in single study","pmids":["12388752"],"is_preprint":false},{"year":2004,"finding":"GS15 (BET1L) functions as part of the syntaxin 5/Ykt6/GS28/GS15 SNARE complex specifically in transport from the early/recycling endosome (EE/RE) to the trans-Golgi network (TGN); antibody inhibition of GS15 blocks STxB transport, and siRNA knockdown of GS15 blocks recombinant STxB transport in HeLa cells. GS15 and Ykt6 redistribute from Golgi to endosomes when the recycling endosome is perturbed by SNX3-overexpression, suggesting cycling between endosomes and Golgi.","method":"In vitro transport assay with Shiga toxin B subunit, antibody inhibition, siRNA knockdown, immunofluorescence with SNX3 overexpression","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vitro transport assay plus siRNA knockdown plus morphological redistribution analysis, multiple orthogonal methods confirming EE/RE-to-TGN function","pmids":["15215310"],"is_preprint":false},{"year":2016,"finding":"COG lobe B sub-complex (COG5-8) physically interacts with v-SNARE GS15 (BET1L) on vesicle-like structures at the Golgi, as demonstrated by super-resolution microscopy showing spatial separation of COG lobe A (on Golgi stacks) and lobe B (on vesicle-like structures where it contacts GS15).","method":"Super-resolution microscopy, co-immunoprecipitation/interaction assays, dominant-negative COG constructs","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — super-resolution microscopy plus physical interaction assays, single lab with two orthogonal methods","pmids":["27385402"],"is_preprint":false},{"year":2021,"finding":"Bet1L (BET1L) protein is localized to the basal lamina of the neuromuscular junction (NMJ) in rat skeletal muscle, and its expression decreases over time in the SOD1G93A ALS rat model, beginning early in disease progression.","method":"Immunofluorescence/immunohistochemistry of rat NMJ tissue, RNA sequencing of iPSC-derived myocytes and ALS rat hindlimb muscle","journal":"Experimental neurology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — localization by immunofluorescence without direct functional consequence established, single lab, no mechanistic follow-up of the NMJ localization","pmids":["34310943"],"is_preprint":false},{"year":2024,"finding":"GS15 (BET1L) undergoes partial mislocalization and degradation upon acute GARP complex disruption (rapid VPS54 depletion via mAID degron), placing GS15 downstream of GARP-dependent vesicle tethering at the TGN.","method":"mAID degron-mediated acute protein degradation, immunofluorescence, western blot","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 3 / Weak — preprint, single lab, GS15 is one of many affected proteins, no direct mechanistic follow-up specific to GS15","pmids":[],"is_preprint":true},{"year":2025,"finding":"Muscle-specific Bet1L (BET1L) knockdown via siRNA injection into hindlimb muscle of ALS (SOD1G93A) and wild-type rats caused increased denervated NMJs, decreased motor neuron size in lumbar spinal cord, and impaired hindlimb motor function; effects were more severe in ALS rats, establishing a functional role for Bet1L in NMJ maintenance.","method":"In vivo siRNA knockdown in rat hindlimb muscle, NMJ immunohistochemistry, motor neuron morphometry, behavioral motor function tests","journal":"Frontiers in neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo loss-of-function with multiple defined phenotypic readouts (NMJ denervation, motor neuron size, motor function), single lab, multiple orthogonal readouts","pmids":["39896335"],"is_preprint":false},{"year":2023,"finding":"A SNP (rs11245997) in the BET1L 3'UTR disrupts miR-140-3p binding and reduces m6A modification (mediated by METTL14/WTAP/ALKBH5), leading to upregulated BET1L expression that promotes colorectal cancer cell growth in vitro and in vivo; BET1L expression was associated with regulation of HSD17B7, CYP27B1, and COMT in the steroid biosynthesis pathway.","method":"Luciferase reporter assays for miRNA binding, m6A methylation assays, RNA-seq pathway analysis, in vitro proliferation assays, in vivo xenograft models, miR-140-3p overexpression rescue","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal functional assays (reporter, m6A, in vitro/in vivo growth, rescue), single lab","pmids":["37115853"],"is_preprint":false}],"current_model":"BET1L (GS15) is a Golgi-resident v-SNARE that forms a defined complex with syntaxin 5, GS28, and Ykt6 to mediate vesicle fusion at the medial-Golgi and in early/recycling endosome-to-TGN transport; it physically interacts with the COG lobe B tethering sub-complex on vesicles, is subject to GARP-dependent trafficking, localizes to the NMJ basal lamina where its loss causes NMJ denervation and motor neuron degeneration, and its expression is post-transcriptionally regulated by miR-140-3p binding and m6A modification."},"narrative":{"mechanistic_narrative":"BET1L (GS15) is a Golgi-resident v-SNARE that mediates membrane fusion in intra-Golgi and endosome-to-Golgi transport [PMID:9242691, PMID:15215310]. It is a 15 kDa integral membrane protein enriched in medial-Golgi cisternae and behaves biochemically as a SNARE [PMID:9242691, PMID:12388752]. BET1L assembles into a defined SNARE complex with syntaxin 5, GS28, and Ykt6, and its loss disrupts Golgi architecture, redistributing Golgi markers into dispersed puncta [PMID:12388752]. This same complex drives transport from the early/recycling endosome to the trans-Golgi network, where antibody inhibition or knockdown of BET1L blocks Shiga toxin B-subunit delivery, and BET1L cycles between endosomes and the Golgi [PMID:15215310]. Its function is integrated with vesicle tethering machinery: BET1L physically contacts the COG lobe B sub-complex on vesicle-like structures [PMID:27385402] and is destabilized upon acute GARP disruption. In skeletal muscle, BET1L localizes to the neuromuscular junction basal lamina, and its knockdown causes NMJ denervation, motor neuron loss, and motor impairment [PMID:39896335]. BET1L expression is post-transcriptionally controlled through miR-140-3p binding and m6A modification at its 3'UTR, with a regulatory SNP linked to colorectal cancer cell growth [PMID:37115853].","teleology":[{"year":1997,"claim":"Established that the mammalian Bet1p homolog GS15/BET1L is a Golgi-enriched integral membrane protein with SNARE biochemical behavior, defining it as a vesicular transport SNARE.","evidence":"Affinity-purified antibodies, immunofluorescence, and biochemical fractionation of a 15 kDa Golgi protein","pmids":["9242691"],"confidence":"Medium","gaps":["No SNARE partners identified","Specific transport step not defined","No loss-of-function phenotype"]},{"year":2002,"claim":"Resolved BET1L's molecular partners and cellular requirement, showing it forms a distinct medial-Golgi SNARE complex with syntaxin 5/GS28/Ykt6 and is essential for Golgi structural integrity.","evidence":"Immuno-EM, reciprocal co-IP, siRNA knockdown with Golgi-fragmentation phenotype, and dominant-negative overexpression","pmids":["12388752"],"confidence":"High","gaps":["Directionality of transport not fully separated from structural maintenance","COPI co-IP relationship mechanistically unresolved"]},{"year":2004,"claim":"Defined a specific transport step for the BET1L SNARE complex — endosome-to-TGN retrograde transport — distinguishing it from ER-to-Golgi function.","evidence":"In vitro Shiga toxin B-subunit transport assay, antibody inhibition, siRNA knockdown, and SNX3-induced redistribution imaging in HeLa cells","pmids":["15215310"],"confidence":"High","gaps":["Mechanism of endosome-Golgi cycling not detailed","Regulation of complex assembly between compartments unknown"]},{"year":2016,"claim":"Connected BET1L to vesicle tethering machinery by showing the COG lobe B sub-complex contacts the v-SNARE on vesicle-like structures, spatially separate from Golgi-stack-bound lobe A.","evidence":"Super-resolution microscopy, physical interaction assays, and dominant-negative COG constructs","pmids":["27385402"],"confidence":"Medium","gaps":["Direct vs. indirect COG-BET1L contact not distinguished","Functional consequence of the interaction for fusion not measured"]},{"year":2021,"claim":"Extended BET1L localization beyond the Golgi to the NMJ basal lamina and linked declining expression to ALS disease progression.","evidence":"Immunohistochemistry of rat NMJ and RNA-seq of iPSC-myocytes and SOD1G93A ALS rat muscle","pmids":["34310943"],"confidence":"Low","gaps":["Localization without established functional consequence","Causal vs. correlative link to ALS unresolved","No mechanistic follow-up of NMJ role"]},{"year":2023,"claim":"Revealed post-transcriptional control of BET1L through a 3'UTR SNP altering miR-140-3p binding and m6A modification, with consequences for colorectal cancer cell growth.","evidence":"Luciferase reporter, m6A assays, RNA-seq pathway analysis, in vitro/in vivo growth assays, and miR-140-3p rescue","pmids":["37115853"],"confidence":"Medium","gaps":["Link between SNARE/Golgi function and proliferation not established","Mechanism connecting BET1L to steroid biosynthesis genes unresolved"]},{"year":2024,"claim":"Placed BET1L downstream of GARP-dependent tethering, showing acute GARP loss leads to its mislocalization and degradation.","evidence":"mAID degron-mediated VPS54 depletion with immunofluorescence and western blot (preprint)","pmids":[],"confidence":"Low","gaps":["Preprint, not peer-reviewed","BET1L is one of many affected proteins","No BET1L-specific mechanistic follow-up"]},{"year":2025,"claim":"Established a functional in vivo requirement for BET1L in NMJ maintenance, with muscle-specific knockdown causing denervation, motor neuron loss, and motor deficits.","evidence":"In vivo siRNA knockdown in rat hindlimb muscle with NMJ immunohistochemistry, motor neuron morphometry, and behavioral testing","pmids":["39896335"],"confidence":"Medium","gaps":["Mechanism linking SNARE/trafficking function to NMJ maintenance unknown","Cell-autonomous vs. non-autonomous contribution unresolved"]},{"year":null,"claim":"How BET1L's core Golgi/endosomal SNARE trafficking function mechanistically connects to its NMJ-maintenance role and to its tumor-promoting activity remains unresolved.","evidence":"No discovery bridges the trafficking mechanism to the disease phenotypes","pmids":[],"confidence":"Low","gaps":["No mechanistic link between vesicle fusion and motor neuron/NMJ phenotype","No structural model of the SNARE complex","Tissue-specific regulation of BET1L function unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0,1,2]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[1,2]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[2]}],"complexes":["syntaxin 5/GS28/Ykt6/GS15 SNARE complex"],"partners":["STX5","GOSR1","YKT6","COG5"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NYM9","full_name":"BET1-like protein","aliases":["Golgi SNARE with a size of 15 kDa","GOS-15","GS15","Vesicle transport protein GOS15"],"length_aa":111,"mass_kda":12.4,"function":"Vesicle SNARE required for targeting and fusion of retrograde transport vesicles with the Golgi complex. Required for the integrity of the Golgi complex (By similarity)","subcellular_location":"Golgi apparatus membrane; Golgi apparatus, trans-Golgi network membrane","url":"https://www.uniprot.org/uniprotkb/Q9NYM9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BET1L","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000177951","cell_line_id":"CID000749","localizations":[{"compartment":"vesicles","grade":3}],"interactors":[{"gene":"SCFD1","stoichiometry":10.0},{"gene":"GOSR1","stoichiometry":10.0},{"gene":"NSF","stoichiometry":10.0},{"gene":"GOSR2","stoichiometry":10.0},{"gene":"STX5","stoichiometry":10.0},{"gene":"VARS","stoichiometry":4.0},{"gene":"VAMP3;VAMP2","stoichiometry":0.2},{"gene":"UBE3B","stoichiometry":0.2},{"gene":"RAB18","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000749","total_profiled":1310},"omim":[{"mim_id":"620201","title":"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIz; CDG2Z","url":"https://www.omim.org/entry/620201"},{"mim_id":"615417","title":"BET1-LIKE PROTEIN; BET1L","url":"https://www.omim.org/entry/615417"},{"mim_id":"610686","title":"UBX DOMAIN PROTEIN 2B; UBXN2B","url":"https://www.omim.org/entry/610686"},{"mim_id":"601118","title":"CALCIUM-MODULATING LIGAND; CAMLG","url":"https://www.omim.org/entry/601118"},{"mim_id":"601023","title":"VALOSIN-CONTAINING PROTEIN; VCP","url":"https://www.omim.org/entry/601023"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Golgi apparatus","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/BET1L"},"hgnc":{"alias_symbol":["GS15","GOLIM3"],"prev_symbol":[]},"alphafold":{"accession":"Q9NYM9","domains":[{"cath_id":"1.20.5","chopping":"10-81","consensus_level":"medium","plddt":93.5586,"start":10,"end":81}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NYM9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NYM9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NYM9-F1-predicted_aligned_error_v6.png","plddt_mean":89.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BET1L","jax_strain_url":"https://www.jax.org/strain/search?query=BET1L"},"sequence":{"accession":"Q9NYM9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NYM9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NYM9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NYM9"}},"corpus_meta":[{"pmid":"15215310","id":"PMC_15215310","title":"Participation of the syntaxin 5/Ykt6/GS28/GS15 SNARE complex in transport from the early/recycling endosome to the trans-Golgi network.","date":"2004","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15215310","citation_count":135,"is_preprint":false},{"pmid":"12388752","id":"PMC_12388752","title":"GS15 forms a SNARE complex with syntaxin 5, GS28, and Ykt6 and is implicated in traffic in the early cisternae of the Golgi apparatus.","date":"2002","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/12388752","citation_count":104,"is_preprint":false},{"pmid":"9242691","id":"PMC_9242691","title":"GS15, a 15-kilodalton Golgi soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) homologous to rbet1.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9242691","citation_count":47,"is_preprint":false},{"pmid":"19376902","id":"PMC_19376902","title":"Phenol degradation in the strictly anaerobic iron-reducing bacterium Geobacter metallireducens GS-15.","date":"2009","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/19376902","citation_count":44,"is_preprint":false},{"pmid":"17644643","id":"PMC_17644643","title":"Plutonium(IV) reduction by the metal-reducing bacteria Geobacter metallireducens GS15 and Shewanella oneidensis MR1.","date":"2007","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/17644643","citation_count":34,"is_preprint":false},{"pmid":"23604678","id":"PMC_23604678","title":"BET1L and TNRC6B associate with uterine fibroid risk among European Americans.","date":"2013","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23604678","citation_count":32,"is_preprint":false},{"pmid":"27385402","id":"PMC_27385402","title":"COG lobe B sub-complex engages v-SNARE GS15 and functions via regulated interaction with lobe A sub-complex.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27385402","citation_count":27,"is_preprint":false},{"pmid":"23892540","id":"PMC_23892540","title":"Variants in BET1L and TNRC6B associate with increasing fibroid volume and fibroid type among European Americans.","date":"2013","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23892540","citation_count":25,"is_preprint":false},{"pmid":"19363069","id":"PMC_19363069","title":"Plutonium(V/VI) Reduction by the Metal-Reducing Bacteria Geobacter metallireducens GS-15 and Shewanella oneidensis MR-1.","date":"2009","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/19363069","citation_count":24,"is_preprint":false},{"pmid":"1901574","id":"PMC_1901574","title":"Acetate catabolism in the dissimilatory iron-reducing isolate GS-15.","date":"1991","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/1901574","citation_count":22,"is_preprint":false},{"pmid":"17067806","id":"PMC_17067806","title":"Effects of the overexpression of a soybean cytosolic glutamine synthetase gene (GS15) linked to organ-specific promoters on growth and nitrogen accumulation of pea plants supplied with ammonium.","date":"2006","source":"Plant physiology and biochemistry : PPB","url":"https://pubmed.ncbi.nlm.nih.gov/17067806","citation_count":16,"is_preprint":false},{"pmid":"24039739","id":"PMC_24039739","title":"Structure determination and biochemical characterization of a putative HNH endonuclease from Geobacter metallireducens GS-15.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24039739","citation_count":15,"is_preprint":false},{"pmid":"37115853","id":"PMC_37115853","title":"Genetic Modulation of BET1L Confers Colorectal Cancer Susceptibility by Reducing miRNA Binding and m6A Modification.","date":"2023","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/37115853","citation_count":14,"is_preprint":false},{"pmid":"12354918","id":"PMC_12354918","title":"A novel HMG A-like protein binds differentially to the AT-rich regions located in the far distal and proximal parts of a soybean glutamine synthetase gene (GS15) promoter.","date":"2002","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12354918","citation_count":10,"is_preprint":false},{"pmid":"34310943","id":"PMC_34310943","title":"Transcriptome analysis using patient iPSC-derived skeletal myocytes: Bet1L as a new molecule possibly linked to neuromuscular junction degeneration in ALS.","date":"2021","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/34310943","citation_count":9,"is_preprint":false},{"pmid":"31275455","id":"PMC_31275455","title":"Replication of GWAS Loci Revealed an Increased Risk of BET1L and H19 Polymorphisms with Intracranial Aneurysm.","date":"2019","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/31275455","citation_count":6,"is_preprint":false},{"pmid":"35477381","id":"PMC_35477381","title":"Risk of uterine leiomyoma based on BET1L rs2280543 single nucleotide polymorphism and vegetarian diet.","date":"2022","source":"BMC women's health","url":"https://pubmed.ncbi.nlm.nih.gov/35477381","citation_count":5,"is_preprint":false},{"pmid":"36737517","id":"PMC_36737517","title":"Genome-wide association study reveals BET1L associated with survival time in the 137,693 Japanese individuals.","date":"2023","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/36737517","citation_count":5,"is_preprint":false},{"pmid":"39260732","id":"PMC_39260732","title":"Quinolone antibiotics stimulate bacterial mercury methylation by Geobacter metallireducens GS-15.","date":"2024","source":"Bioresource technology","url":"https://pubmed.ncbi.nlm.nih.gov/39260732","citation_count":4,"is_preprint":false},{"pmid":"39896335","id":"PMC_39896335","title":"Muscle-specific Bet1L knockdown induces neuromuscular denervation, motor neuron degeneration, and motor dysfunction in a rat model of familial ALS.","date":"2025","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/39896335","citation_count":3,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.05.16.25327746","title":"Genetic and Epidemiologic Assessment of Mandibular Cortical Indices and Bone Mineral Density in Peripubertal Children: The Generation R Study","date":"2025-05-16","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.16.25327746","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.12.642795","title":"Genome-Wide CRISPR Screening Identifies Cellular Factors Controlling Nonviral Genome Editing Efficiency","date":"2025-03-14","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.12.642795","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.07.617053","title":"Acute GARP depletion disrupts vesicle transport, leading to severe defects in sorting, secretion, and O-glycosylation","date":"2024-10-07","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.07.617053","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14038,"output_tokens":2208,"usd":0.037617,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9154,"output_tokens":2813,"usd":0.058048,"stage2_stop_reason":"end_turn"},"total_usd":0.095665,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"GS15 (BET1L) is a 15 kDa integral membrane protein highly enriched in Golgi membranes that behaves biochemically as a SNARE protein, identified as a mammalian homolog of yeast Bet1p involved in vesicular transport.\",\n      \"method\": \"Affinity-purified polyclonal antibodies, indirect immunofluorescence microscopy, biochemical fractionation/characterization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct biochemical characterization of protein behavior as a SNARE, subcellular localization by immunofluorescence and fractionation, single lab with two orthogonal methods\",\n      \"pmids\": [\"9242691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GS15 (BET1L) localizes to medial-cisternae of the Golgi apparatus (not the IC/ER exit sites), exists in a distinct SNARE complex with syntaxin 5, GS28, and Ykt6 (but not with ER-to-Golgi-exclusive SNAREs), co-immunoprecipitates with COPI coat components from Golgi extracts, and is essential for normal Golgi structure — its knockdown redistributes Golgi markers into small dotty/diffuse patterns.\",\n      \"method\": \"Immuno-electron microscopy, co-immunoprecipitation, siRNA knockdown, overexpression of dominant-negative mutants, indirect immunofluorescence\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, immuno-EM localization, loss-of-function siRNA with defined Golgi phenotype, dominant-negative overexpression, multiple orthogonal methods in single study\",\n      \"pmids\": [\"12388752\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GS15 (BET1L) functions as part of the syntaxin 5/Ykt6/GS28/GS15 SNARE complex specifically in transport from the early/recycling endosome (EE/RE) to the trans-Golgi network (TGN); antibody inhibition of GS15 blocks STxB transport, and siRNA knockdown of GS15 blocks recombinant STxB transport in HeLa cells. GS15 and Ykt6 redistribute from Golgi to endosomes when the recycling endosome is perturbed by SNX3-overexpression, suggesting cycling between endosomes and Golgi.\",\n      \"method\": \"In vitro transport assay with Shiga toxin B subunit, antibody inhibition, siRNA knockdown, immunofluorescence with SNX3 overexpression\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vitro transport assay plus siRNA knockdown plus morphological redistribution analysis, multiple orthogonal methods confirming EE/RE-to-TGN function\",\n      \"pmids\": [\"15215310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"COG lobe B sub-complex (COG5-8) physically interacts with v-SNARE GS15 (BET1L) on vesicle-like structures at the Golgi, as demonstrated by super-resolution microscopy showing spatial separation of COG lobe A (on Golgi stacks) and lobe B (on vesicle-like structures where it contacts GS15).\",\n      \"method\": \"Super-resolution microscopy, co-immunoprecipitation/interaction assays, dominant-negative COG constructs\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — super-resolution microscopy plus physical interaction assays, single lab with two orthogonal methods\",\n      \"pmids\": [\"27385402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Bet1L (BET1L) protein is localized to the basal lamina of the neuromuscular junction (NMJ) in rat skeletal muscle, and its expression decreases over time in the SOD1G93A ALS rat model, beginning early in disease progression.\",\n      \"method\": \"Immunofluorescence/immunohistochemistry of rat NMJ tissue, RNA sequencing of iPSC-derived myocytes and ALS rat hindlimb muscle\",\n      \"journal\": \"Experimental neurology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — localization by immunofluorescence without direct functional consequence established, single lab, no mechanistic follow-up of the NMJ localization\",\n      \"pmids\": [\"34310943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GS15 (BET1L) undergoes partial mislocalization and degradation upon acute GARP complex disruption (rapid VPS54 depletion via mAID degron), placing GS15 downstream of GARP-dependent vesicle tethering at the TGN.\",\n      \"method\": \"mAID degron-mediated acute protein degradation, immunofluorescence, western blot\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — preprint, single lab, GS15 is one of many affected proteins, no direct mechanistic follow-up specific to GS15\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Muscle-specific Bet1L (BET1L) knockdown via siRNA injection into hindlimb muscle of ALS (SOD1G93A) and wild-type rats caused increased denervated NMJs, decreased motor neuron size in lumbar spinal cord, and impaired hindlimb motor function; effects were more severe in ALS rats, establishing a functional role for Bet1L in NMJ maintenance.\",\n      \"method\": \"In vivo siRNA knockdown in rat hindlimb muscle, NMJ immunohistochemistry, motor neuron morphometry, behavioral motor function tests\",\n      \"journal\": \"Frontiers in neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo loss-of-function with multiple defined phenotypic readouts (NMJ denervation, motor neuron size, motor function), single lab, multiple orthogonal readouts\",\n      \"pmids\": [\"39896335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"A SNP (rs11245997) in the BET1L 3'UTR disrupts miR-140-3p binding and reduces m6A modification (mediated by METTL14/WTAP/ALKBH5), leading to upregulated BET1L expression that promotes colorectal cancer cell growth in vitro and in vivo; BET1L expression was associated with regulation of HSD17B7, CYP27B1, and COMT in the steroid biosynthesis pathway.\",\n      \"method\": \"Luciferase reporter assays for miRNA binding, m6A methylation assays, RNA-seq pathway analysis, in vitro proliferation assays, in vivo xenograft models, miR-140-3p overexpression rescue\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal functional assays (reporter, m6A, in vitro/in vivo growth, rescue), single lab\",\n      \"pmids\": [\"37115853\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BET1L (GS15) is a Golgi-resident v-SNARE that forms a defined complex with syntaxin 5, GS28, and Ykt6 to mediate vesicle fusion at the medial-Golgi and in early/recycling endosome-to-TGN transport; it physically interacts with the COG lobe B tethering sub-complex on vesicles, is subject to GARP-dependent trafficking, localizes to the NMJ basal lamina where its loss causes NMJ denervation and motor neuron degeneration, and its expression is post-transcriptionally regulated by miR-140-3p binding and m6A modification.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"BET1L (GS15) is a Golgi-resident v-SNARE that mediates membrane fusion in intra-Golgi and endosome-to-Golgi transport [#0, #2]. It is a 15 kDa integral membrane protein enriched in medial-Golgi cisternae and behaves biochemically as a SNARE [#0, #1]. BET1L assembles into a defined SNARE complex with syntaxin 5, GS28, and Ykt6, and its loss disrupts Golgi architecture, redistributing Golgi markers into dispersed puncta [#1]. This same complex drives transport from the early/recycling endosome to the trans-Golgi network, where antibody inhibition or knockdown of BET1L blocks Shiga toxin B-subunit delivery, and BET1L cycles between endosomes and the Golgi [#2]. Its function is integrated with vesicle tethering machinery: BET1L physically contacts the COG lobe B sub-complex on vesicle-like structures [#3] and is destabilized upon acute GARP disruption [#5]. In skeletal muscle, BET1L localizes to the neuromuscular junction basal lamina, and its knockdown causes NMJ denervation, motor neuron loss, and motor impairment [#6]. BET1L expression is post-transcriptionally controlled through miR-140-3p binding and m6A modification at its 3'UTR, with a regulatory SNP linked to colorectal cancer cell growth [#7].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established that the mammalian Bet1p homolog GS15/BET1L is a Golgi-enriched integral membrane protein with SNARE biochemical behavior, defining it as a vesicular transport SNARE.\",\n      \"evidence\": \"Affinity-purified antibodies, immunofluorescence, and biochemical fractionation of a 15 kDa Golgi protein\",\n      \"pmids\": [\"9242691\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No SNARE partners identified\", \"Specific transport step not defined\", \"No loss-of-function phenotype\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Resolved BET1L's molecular partners and cellular requirement, showing it forms a distinct medial-Golgi SNARE complex with syntaxin 5/GS28/Ykt6 and is essential for Golgi structural integrity.\",\n      \"evidence\": \"Immuno-EM, reciprocal co-IP, siRNA knockdown with Golgi-fragmentation phenotype, and dominant-negative overexpression\",\n      \"pmids\": [\"12388752\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Directionality of transport not fully separated from structural maintenance\", \"COPI co-IP relationship mechanistically unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined a specific transport step for the BET1L SNARE complex — endosome-to-TGN retrograde transport — distinguishing it from ER-to-Golgi function.\",\n      \"evidence\": \"In vitro Shiga toxin B-subunit transport assay, antibody inhibition, siRNA knockdown, and SNX3-induced redistribution imaging in HeLa cells\",\n      \"pmids\": [\"15215310\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of endosome-Golgi cycling not detailed\", \"Regulation of complex assembly between compartments unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Connected BET1L to vesicle tethering machinery by showing the COG lobe B sub-complex contacts the v-SNARE on vesicle-like structures, spatially separate from Golgi-stack-bound lobe A.\",\n      \"evidence\": \"Super-resolution microscopy, physical interaction assays, and dominant-negative COG constructs\",\n      \"pmids\": [\"27385402\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs. indirect COG-BET1L contact not distinguished\", \"Functional consequence of the interaction for fusion not measured\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Extended BET1L localization beyond the Golgi to the NMJ basal lamina and linked declining expression to ALS disease progression.\",\n      \"evidence\": \"Immunohistochemistry of rat NMJ and RNA-seq of iPSC-myocytes and SOD1G93A ALS rat muscle\",\n      \"pmids\": [\"34310943\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Localization without established functional consequence\", \"Causal vs. correlative link to ALS unresolved\", \"No mechanistic follow-up of NMJ role\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Revealed post-transcriptional control of BET1L through a 3'UTR SNP altering miR-140-3p binding and m6A modification, with consequences for colorectal cancer cell growth.\",\n      \"evidence\": \"Luciferase reporter, m6A assays, RNA-seq pathway analysis, in vitro/in vivo growth assays, and miR-140-3p rescue\",\n      \"pmids\": [\"37115853\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Link between SNARE/Golgi function and proliferation not established\", \"Mechanism connecting BET1L to steroid biosynthesis genes unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Placed BET1L downstream of GARP-dependent tethering, showing acute GARP loss leads to its mislocalization and degradation.\",\n      \"evidence\": \"mAID degron-mediated VPS54 depletion with immunofluorescence and western blot (preprint)\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Preprint, not peer-reviewed\", \"BET1L is one of many affected proteins\", \"No BET1L-specific mechanistic follow-up\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Established a functional in vivo requirement for BET1L in NMJ maintenance, with muscle-specific knockdown causing denervation, motor neuron loss, and motor deficits.\",\n      \"evidence\": \"In vivo siRNA knockdown in rat hindlimb muscle with NMJ immunohistochemistry, motor neuron morphometry, and behavioral testing\",\n      \"pmids\": [\"39896335\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking SNARE/trafficking function to NMJ maintenance unknown\", \"Cell-autonomous vs. non-autonomous contribution unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How BET1L's core Golgi/endosomal SNARE trafficking function mechanistically connects to its NMJ-maintenance role and to its tumor-promoting activity remains unresolved.\",\n      \"evidence\": \"No discovery bridges the trafficking mechanism to the disease phenotypes\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No mechanistic link between vesicle fusion and motor neuron/NMJ phenotype\", \"No structural model of the SNARE complex\", \"Tissue-specific regulation of BET1L function unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [\"syntaxin 5/GS28/Ykt6/GS15 SNARE complex\"],\n    \"partners\": [\"STX5\", \"GOSR1\", \"YKT6\", \"COG5\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}